Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2012-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/cclm-2011-0650PMID 22850059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production

  2011cited by this paper
• Human RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus in Canine Cells

  2010cited by this paper
• Continuous cell lines as a production system for influenza vaccines

  2009cited by this paper
• Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production

  2007cited by this paper
• Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA.

  2004cited by this paper
• Influenza vaccines generated by reverse genetics.

  2004cited by this paper
• A DNA transfection system for generation of influenza A virus from eight plasmids.

  2000cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.

  1999cited by this paper
• Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

  1998cited by this paper
• Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective

  1995cited by this paper
• Future influenza vaccines and the use of genetic recombinants.

  1969cited by this paper

• Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.

  2026cites this paper
• Rapid production of synthetic influenza vaccines.

  2015cites this paper
• Influenza Cell-Culture Vaccine Production

  2014cites this paper
• Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

  2013cites this paper
• Pandemics Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to

  2013cites this paper
• Synthetic Generation of Influenza Vaccine Viruses for Rapid Response To

  year unknowncites this paper